S

Sirnaomics, Inc.

74 employees

Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.

Investor insights

Sectors invested in

Biotechnology3
Health Care2
Life Science2
Therapeutics1

Funding rounds participated in

$19M sweet spot round size

Most of their 3 investments are in rounds between $10M and $27M

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Medical Device
RNAi
Biotech
Rare Diseases
Pharmaceutical
Drug Development
Biopharma

Date founded

2007

Investments made

E

EDIRNA raised undisclosed on July 5, 2023

Investors: Sirnaomics, Inc.

R

RNAimmune raised $27M on March 29, 2022

Investors: Sirnaomics, Inc.

R

RNAimmune raised $10M on April 21, 2021

Investors: Sirnaomics, Inc.

Funding rounds raised

Total raised

$105M

from 3 investors over 3 rounds

S

Sirnaomics, Inc. raised $105M on October 23, 2020

Investors: 阳光融汇资本投资管理有限公司 and Sangel Capital

S

Sirnaomics, Inc. raised $25M on June 6, 2018

Investors: 广州越秀产业投资基金管理有限公司

FAQ